AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally.
It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients.
In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO.
Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee.
It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists.
Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.
Country | United States |
IPO Date | Jan 30, 2015 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 71 |
CEO | Himanshu N. Patel |
Contact Details
Address: 400 Chesapeake Drive Redwood City, California United States | |
Website | https://avinger.com |
Stock Details
Ticker Symbol | AVGR |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001506928 |
CUSIP Number | 053734604 |
ISIN Number | US0537348775 |
Employer ID | 20-8873453 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Himanshu N. Patel | Chief Technology Officer |
Keith Schaefer | Chief Operating Officer |
Dr. Jaafer Golzar FACC, M.D. | Chief Medical Officer |
Philip R. Preuss | Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 13, 2025 | DEFR14A | Filing |
Jan 13, 2025 | DEFA14A | Filing |
Jan 03, 2025 | 8-K | Current Report |
Jan 02, 2025 | 8-K | Current Report |
Dec 23, 2024 | DEF 14A | Filing |
Dec 19, 2024 | 8-K | Current Report |
Dec 13, 2024 | 8-K | Current Report |
Dec 11, 2024 | 8-K | Current Report |
Dec 11, 2024 | PRE 14A | Filing |
Nov 22, 2024 | 8-K | Current Report |